After the ‘Jackpot’ of Hanmi, other companies’ pipelines attract interests

As Hanmi Pharm, which put all its effort in R&D, signed 6 gigantic license agreements with multinational pharmaceutical companies only this year, other domestic pharmaceutical companies’ pipelines have started to attract interests of others.

According to the industry concerned and the securities industry, while domestic companies, such as Dong-A ST, Green Cross, Chong Kun Dang and Viromed, are...